I’m excited to share a deeper look into my professional journey in oncology research, clinical development, and regulatory science. Over the past 30+ years, I’ve had the opportunity to work across global biopharma organizations, advisory boards, and academic institutions, all focused on advancing patient-centered innovation. Here is my biography.

I’m pleased to share a biography that reflects my journey as a global pharmaceutical and biotechnology executive across medical affairs, clinical development, regulatory strategy, and commercialization. Over the past three decades, I’ve had the opportunity to lead across respiratory, rare disease, oncology, endocrinology, infectious disease, and global market expansion while building teams, advancing innovation, and supporting product launches worldwide. Here is my biography.

I am excited to share a more complete view of my professional journey—one shaped by clinical research, oncology development, mentorship, and a passion for improving patient outcomes. Over the past two decades, I’ve had the privilege of working across pharma, biotech, site networks, and academia, experiences that continue to inspire my commitment to meaningful innovation in clinical development. Here is my biography.

Michael Buckley is a biotechnology executive with nearly 40 years of experience leading the development and commercialization of complex biologics. Known for his ability to translate advanced science into strategic and operational success, he has played a pivotal role in bringing innovative therapies to market while guiding organizations through transformation and growth.

I’m excited to share a comprehensive look at my professional journey across clinical medicine, translational science, biotechnology leadership, and the evolving landscape of precision and AI-enabled drug development. Over the past two decades, I’ve been fortunate to work with extraordinary teams, lead high-impact programs, and contribute to the growth of organizations committed to improving patient lives. Here is my biography.

I’m honored to share my professional biography, which reflects a career devoted to the development and commercialization of vaccines, anti-infectives, and diagnostics that address global microbial threats. My journey has taken me from regulatory service at the FDA to executive leadership in biotech and government programs shaping the future of infectious disease therapeutics.

After over 35 years of experience in nursing, regulatory affairs, and clinical development, I’m excited to share a bit more about my professional journey. From leading global clinical trials to serving on school boards, I’ve remained passionate about improving patient outcomes and advancing healthcare innovation. Here is my biography.

After decades of leadership in pharmaceutical R&D, I’m excited to share a detailed look at my career journey—from drug discovery to biomarker development, strategic consulting, and beyond. I’ve been fortunate to work alongside exceptional teams and contribute to the development of transformative therapies. Here is my biography.

Over the course of my career, I’ve been privileged to serve in roles that blend scientific discovery, corporate leadership, and global health impact. From developing the first anti-TNF inhibitor to founding multiple biotech companies and leading critical medical research in the U.S. Navy, my work has always centered on advancing therapies that change lives. I’m excited to share a detailed look at my professional journey, values, and vision for the future. Here is my biography.

I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

Ken Arnold is an accomplished medical device executive recognized for leading breakthrough innovations in laser technology and transforming companies through strategic vision and hands-on leadership. As CEO and Co-founder of Precise Light Surgical, he raised $17 million and guided the company from concept to commercialization with a novel tissue-sparing microsurgical platform. His earlier roles at Laserscope and Iridex underscore a consistent track record of scaling innovation into clinical and commercial success, including driving a $715 million acquisition and spearheading next-generation glaucoma treatments. With deep technical expertise, strong investor and clinical relationships, and a relentless focus on patient impact, Ken has built a career defined by precision, performance, and purpose.

After 25+ years working at the intersection of science and strategy in cell and gene therapy, I’m excited to share a comprehensive look into my professional journey—from hands-on scientific innovation to leadership across CDMOs, biotech, and academic institutions. My passion lies in building high-impact teams, developing therapies that matter, and bridging ideas to execution. Here is my biography.

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.

I’m thrilled to share my updated executive biography, highlighting my journey and experiences in the biotech and pharma industries. With over 30 years of experience, I’ve had the privilege of leading clinical operations, managing complex programs, and working with exceptional teams to drive advancements in clinical research. My recent role as Senior Director of Clinical Operations at uniQure allowed me to deepen my expertise in clinical development, cross-functional team leadership, and strategic program management. I’m passionate about leveraging this experience to contribute to innovative projects and impactful organizations. Thank you for taking the time to read about my professional journey. I look forward to connecting and exploring new opportunities where I can bring my skills and dedication to make a difference.